Literature DB >> 33477348

Efficient Production of Chimeric Hepatitis B Virus-Like Particles Bearing an Epitope of Hepatitis E Virus Capsid by Transient Expression in Nicotiana benthamiana.

Gergana Zahmanova1,2, Milena Mazalovska1, Katerina Takova1, Valentina Toneva1,3, Ivan Minkov2,3, Hadrien Peyret4, George Lomonossoff4.   

Abstract

The core antigen of hepatitis B virus (HBcAg) is capable of self-assembly into virus-like particles (VLPs) when expressed in a number of heterologous systems. Such VLPs are potential carriers of foreign antigenic sequences for vaccine design. In this study, we evaluated the production of chimeric HBcAg VLPs presenting a foreign epitope on their surface, the 551-607 amino acids (aa) immunological epitope of the ORF2 capsid protein of hepatitis E virus. A chimeric construct was made by the insertion of 56 aa into the immunodominant loop of the HBcAg. The sequences encoding the chimera were inserted into the pEAQ-HT vector and infiltrated into Nicotiana benthamiana leaves. The plant-expressed chimeric HBcHEV ORF2 551-607 protein was recognized by an anti-HBcAg mAb and anti-HEV IgG positive swine serum. Electron microscopy showed that plant-produced chimeric protein spontaneously assembled into "knobbly" ~34 nm diameter VLPs. This study shows that HBcAg is a promising carrier platform for the neutralizing epitopes of hepatitis E virus (HEV) and the chimeric HBcAg/HEV VLPs could be a candidate for a bivalent vaccine.

Entities:  

Keywords:  chimeric HBcHEV VLPs; hepatitis B capsid antigen; hepatitis E capsid protein; plant transient expression; virus-like particles

Year:  2021        PMID: 33477348      PMCID: PMC7830250          DOI: 10.3390/life11010064

Source DB:  PubMed          Journal:  Life (Basel)        ISSN: 2075-1729


  50 in total

1.  Generation in yeast and antigenic characterization of hepatitis E virus capsid protein virus-like particles.

Authors:  Martynas Simanavicius; Paulius Lukas Tamosiunas; Rasa Petraityte-Burneikiene; Reimar Johne; Rainer G Ulrich; Aurelija Zvirbliene; Indre Kucinskaite-Kodze
Journal:  Appl Microbiol Biotechnol       Date:  2017-11-15       Impact factor: 4.813

Review 2.  The development of a recombinant hepatitis E vaccine HEV 239.

Authors:  Shao-Wei Li; Qinjian Zhao; Ting Wu; Shu Chen; Jun Zhang; Ning-Shao Xia
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding.

Authors:  Tom S Y Guu; Zheng Liu; Qiaozhen Ye; Douglas A Mata; Kunpeng Li; Changcheng Yin; Jingqiang Zhang; Yizhi Jane Tao
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-21       Impact factor: 11.205

4.  The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen.

Authors:  D R Milich; A McLachlan
Journal:  Science       Date:  1986-12-12       Impact factor: 47.728

5.  Consensus proposals for classification of the family Hepeviridae.

Authors:  Donald B Smith; Peter Simmonds; Shahid Jameel; Suzanne U Emerson; Tim J Harrison; Xiang-Jin Meng; Hiroaki Okamoto; Wim H M Van der Poel; Michael A Purdy
Journal:  J Gen Virol       Date:  2014-07-02       Impact factor: 3.891

6.  SWISS-MODEL: homology modelling of protein structures and complexes.

Authors:  Andrew Waterhouse; Martino Bertoni; Stefan Bienert; Gabriel Studer; Gerardo Tauriello; Rafal Gumienny; Florian T Heer; Tjaart A P de Beer; Christine Rempfer; Lorenza Bordoli; Rosalba Lepore; Torsten Schwede
Journal:  Nucleic Acids Res       Date:  2018-07-02       Impact factor: 16.971

Review 7.  Transmission of Hepatitis E Virus in Developing Countries.

Authors:  Mohammad S Khuroo; Mehnaaz S Khuroo; Naira S Khuroo
Journal:  Viruses       Date:  2016-09-20       Impact factor: 5.048

8.  Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome.

Authors:  A W Tam; M M Smith; M E Guerra; C C Huang; D W Bradley; K E Fry; G R Reyes
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

9.  Expression, Purification and Characterization of the Hepatitis E Virus Like-Particles in the Pichia pastoris.

Authors:  Jyoti Gupta; Sheetal Kaul; Akriti Srivastava; Neha Kaushik; Sukanya Ghosh; Chandresh Sharma; Gaurav Batra; Manidipa Banerjee; Baibaswata Nayak; C T Ranjith-Kumar; Milan Surjit
Journal:  Front Microbiol       Date:  2020-02-06       Impact factor: 5.640

View more
  7 in total

Review 1.  Plant-Derived Human Vaccines: Recent Developments.

Authors:  Jennifer Stander; Sandiswa Mbewana; Ann E Meyers
Journal:  BioDrugs       Date:  2022-07-12       Impact factor: 7.744

Review 2.  Plant-derived VLP: a worthy platform to produce vaccine against SARS-CoV-2.

Authors:  Farshad Hemmati; Mohsen Hemmati-Dinarvand; Marziye Karimzade; Daria Rutkowska; Mohammad Hadi Eskandari; Sayyad Khanizadeh; Alireza Afsharifar
Journal:  Biotechnol Lett       Date:  2021-11-27       Impact factor: 2.716

Review 3.  Plant-Derived Recombinant Vaccines against Zoonotic Viruses.

Authors:  Gergana Zahmanova; Katerina Takova; Rumyana Valkova; Valentina Toneva; Ivan Minkov; Anton Andonov; Georgi L Lukov
Journal:  Life (Basel)       Date:  2022-01-21

Review 4.  Plant-Based Vaccines in Combat against Coronavirus Diseases.

Authors:  Benita Ortega-Berlanga; Tomasz Pniewski
Journal:  Vaccines (Basel)       Date:  2022-01-18

Review 5.  Development of virus-like particles-based vaccines against coronaviruses.

Authors:  Chean Yeah Yong; Winnie Pui Pui Liew; Hui Kian Ong; Chit Laa Poh
Journal:  Biotechnol Prog       Date:  2022-08-05

Review 6.  A Comprehensive Overview on the Production of Vaccines in Plant-Based Expression Systems and the Scope of Plant Biotechnology to Combat against SARS-CoV-2 Virus Pandemics.

Authors:  Manu Kumar; Nisha Kumari; Nishant Thakur; Shashi Kant Bhatia; Ganesh Dattatraya Saratale; Gajanan Ghodake; Bhupendra M Mistry; Hemasundar Alavilli; D S Kishor; Xueshi Du; Sang-Min Chung
Journal:  Plants (Basel)       Date:  2021-06-15

7.  Construction of SARS-CoV-2 virus-like particles in plant.

Authors:  Ki-Beom Moon; Jae-Heung Jeon; Hyukjun Choi; Ji-Sun Park; Su-Jin Park; Hyo-Jun Lee; Jeong Mee Park; Hye Sun Cho; Jae Sun Moon; Hyunwoo Oh; Sebyung Kang; Hugh S Mason; Suk-Yoon Kwon; Hyun-Soon Kim
Journal:  Sci Rep       Date:  2022-01-19       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.